卒中、房颤诊断时机与死亡风险
本研究基于Penn AF Free研究建立新发卒中事件队列,按房颤诊断时机分为窦性心律、已知房颤和卒中后诊断房颤三组,比较死亡风险。
要点
- 卒中后6个月内诊断房颤者全因死亡风险最高,独立于合并症和抗血栓治疗。
- 已知房颤患者死亡风险在调整后不再显著。
- 卒中后房颤诊断时机对预后评估有重要价值。
核心结论
- 卒中后6个月内诊断房颤组全因死亡风险最高,且不能由合并症或抗血栓治疗解释。
研究设计与样本
- 基于Penn AF Free研究建立新发缺血性卒中事件队列,共纳入1489例。
- 通过链接国家死亡指数至2017年6月30日识别死亡事件。
- 使用Cox比例风险模型评估卒中亚型与死亡的关联。
主要发现
- 中位随访4.9年(四分位距1.9-6.8),共发生686例死亡。
- 年化死亡率:卒中无房颤组8.8%,已知房颤组12.2%,卒中后≤6个月诊断房颤组15.8%,>6个月组12.7%。
- 已知房颤组死亡风险高于卒中无房颤组,但调整后不显著。
临床怎么用
- 对缺血性卒中患者应关注房颤诊断时机,卒中后6个月内诊断房颤者死亡风险最高。
- 评估卒中后房颤患者预后时需考虑诊断时机,而非仅看房颤是否存在。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the prognosis of patients with ischemic stroke according to the timing of an atrial fibrillation (AF) diagnosis, we created an inception cohort of incident stroke events and compared the risk of death between patients with stroke with (1) sinus rhythm, (2) known AF (KAF), and (3) AF diagnosed after stroke (AFDAS). METHODS: We used the Penn AF Free study to create an inception cohort of patients with incident stroke. Mortality events were identified after linkage with the National Death Index through June 30, 2017. We also evaluated initiation of anticoagulants and antiplatelets across the study duration. Cox proportional hazards models evaluated associations between stroke subtypes and death. RESULTS: We identified 1,489 individuals who developed an incident ischemic stroke event: 985 did not develop AF at any point during the study period, 215 had KAF before stroke, 160 had AF detected ≤6 months after stroke, and 129 had AF detected >6 months after stroke. After a median follow-up of 4.9 years (interquartile range 1.9-6.8), 686 deaths occurred. The annualized mortality rate was 8.8% in the stroke, no AF group; 12.2% in the KAF group; 15.8% in the AFDAS ≤6 months group; and 12.7% in the AFDAS >6 months group. Patients in the AFDAS ≤6 months group had the highest independent risk of all-cause mortality even after multivariable adjustment for demographics, clinical risk factors, and the use of antithrombotic therapies (hazard ratio 1.62 [1.22-2.14]). Compared to the stroke, no AF group, those with KAF had a higher mortality risk that was rendered nonsignificant after adjustment. CONCLUSIONS: The AFDAS group had the highest risk of death, which was not explained by comorbidities or use of antithrombotic therapies.
引用
- Bhatla A, Borovskiy Y, Katz R, et al. Stroke, Timing of Atrial Fibrillation Diagnosis, and Risk of Death. Neurology. 2021. PMID: 33536273. doi:10.1212/WNL.0000000000011633
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。